Scarica l'app Stockscreener
111.04
2.70%
2.92
Dopo l'orario di chiusura:
112.22
1.18
+1.06%
Oruka Therapeutics Inc Borsa (ORKA) Ultime notizie
Oruka Therapeutics (NASDAQ:ORKA) Cut to "Sell" at Wall Street Zen - MarketBeat
ORKA Stock Is Soaring After Psoriasis Trial Results — Here's Why BTIG Hiked Its Price Target By 94% - Stocktwits
Oruka Therapeutics GC Paul Quinlan sells $5.64m stock By Investing.com - Investing.com Australia
Oruka Therapeutics GC Paul Quinlan sells $5.64m stock - Investing.com
Oruka Therapeutics senior vice president Arjun Agarwal sells $1.06m By Investing.com - Investing.com Australia
Insider Selling: Oruka Therapeutics (NASDAQ:ORKA) SVP Sells 10,000 Shares of Stock - MarketBeat
Oruka Therapeutics senior vice president Arjun Agarwal sells $1.06m - Investing.com
Oruka Therapeutics Insider Sold Shares Worth $5,641,409, According to a Recent SEC Filing - marketscreener.com
Oruka Therapeutics Insider Sold Shares Worth $1,066,572, According to a Recent SEC Filing - marketscreener.com
Oruka Therapeutics stock hits 52-week high at 109.56 USD By Investing.com - Investing.com Nigeria
Oruka Therapeutics stock hits 52-week high at 109.56 USD - Investing.com
Handelsbanken Fonder AB Purchases Shares of 160,900 Oruka Therapeutics, Inc. $ORKA - MarketBeat
Sei Investments Co. Raises Position in Oruka Therapeutics, Inc. $ORKA - MarketBeat
Oruka Therapeutics (ORKA) On Its Earnings Miss And Whether The Valuation Still Holds - Sahm
A Quick Look at Today's Ratings for Oruka Therapeutics(ORKA.US), With a Forecast Between $133 to $180 - Moomoo
Dimensional Fund Advisors LP Makes New Investment in Oruka Therapeutics, Inc. $ORKA - MarketBeat
Oruka Therapeutics Inc (ORKA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Wedbush Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $165 - Moomoo
Oruka Therapeutics (ORKA) Is Up 10.9% After Wider-Than-Expected Q2 Loss From R&D InvestmentHas The Bull Case Changed? - simplywall.st
Oruka Therapeutics' (ORKA) "Buy" Rating Reaffirmed at Guggenheim - MarketBeat
Oruka Therapeutics' (ORKA) Outperform Rating Reiterated at Wedbush - MarketBeat
Oruka Therapeutics (NASDAQ:ORKA) Given "Buy" Rating at BTIG Research - MarketBeat
Oruka Therapeutics (NASDAQ:ORKA) Sets New 12-Month HighStill a Buy? - MarketBeat
ORUKA THERAPEUTICS INC : LEERINK PARTNERS RAISES TARGET PRICE TO $179 FROM $162 - Bitget
Oruka Therapeutics Releases Q2 2026 Financial Results - AlphaStreet
Oruka Therapeutics Q2 Loss Widens - marketscreener.com
Oruka Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Oruka Therapeutics Q2 EPS of $(0.55) misses estimates - scanx.trade
Oruka Therapeutics (NASDAQ:ORKA) Issues Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
Earnings Flash (ORKA) Oruka Therapeutics Posts Q2 Loss $0.55 a Share, vs. FactSet Est of $0.53 Loss - marketscreener.com
Oruka Therapeutics Q2 net loss widens on higher R&D costs - TradingView
Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
Oruka Therapeutics reports Q2 2026 results: $1.1B cash; net loss $41.2M in quarter - TradingView
Press Release: Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Moomoo
Oruka Therapeutics (ORKA) Earnings Date and Reports 2026 - MarketBeat
The Manufacturers Life Insurance Company Acquires 11,205 Shares of Oruka Therapeutics, Inc. $ORKA - MarketBeat
Oruka Therapeutics (NASDAQ:ORKA) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Oruka Therapeutics stock hits 52-week high at 100.11 USD By Investing.com - Investing.com Nigeria
Oruka Therapeutics stock hits 52-week high at 100.11 USD - Investing.com
HALOZYME REPORTS RECORD SECOND QUARTER 2026 RESULTS, BEATS ESTIMATES AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE - PR Newswire
Oruka Therapeutics (NASDAQ:ORKA) Hits New 12-Month HighWhat's Next? - MarketBeat
Oruka Therapeutics, Inc. (ORKA) options chain - Yahoo Finance Australia
Oruka Therapeutics (ORKA) Projected to Announce Earnings on Monday - MarketBeat
Oruka Therapeutics Is Priced For PerfectionIt’s Time To Cash Out (NASDAQ:ORKA) - Seeking Alpha
Perceptive Advisors LLC Sells 81,000 Shares of Oruka Therapeutics, Inc. $ORKA - MarketBeat
Oruka Therapeutics, Inc. $ORKA Stock Position Increased by Avidity Partners Management LP - MarketBeat
Oruka Therapeutics, Inc. (ORKA) Stock Analysis: A 51% Upside Potential in the Biotech Arena - DirectorsTalk Interviews
Remedium Capital Partners LLC Raises Holdings in Oruka Therapeutics, Inc. $ORKA - MarketBeat
Oruka Therapeutics stock reaches 52-week high at 97.81 USD By Investing.com - Investing.com Nigeria
Oruka Therapeutics (NASDAQ:ORKA) Sets New 52-Week HighTime to Buy? - MarketBeat
Oruka Therapeutics Inc (ORKA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Oruka Therapeutics Inc (ORKA) Institutional Confidence - TradingKey
Oruka Therapeutics Inc (ORKA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Oruka Therapeutics Inc (ORKA) Balance Sheet - TradingKey
Oruka Therapeutics Inc (ORKA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Oruka Therapeutics Inc (ORKA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):